Acumen Pharmaceuticals, Inc. (ABOS) stock has reached a new 52-week low, trading at $1.52, with a current market capitalization of $92.5 million. According to InvestingPro analysis, the stock appears ...

Artificial intelligence stocks look strong for the future, but Kinaxis stock could be the best buy out there. The post ...

The Tax Cuts and Jobs Act lowered tax rates for most taxpayers and nearly doubled the standard deduction. Most provisions of ...

Asset manager Grayscale Investments has launched an investment fund for Dogecoin, the most popular memecoin by market cap.

Bitcoin ( BTC) is trading less than 5% below its all-time high of $109,500, yet demand for leverage in perpetual contracts ...

Premium bonds cost more than their face value. Find out how these bonds work and see if they're a worthwhile investment.

NYU finance professor David Yermack weighs in on the potential risks and benefits of investing in crypto and more ...

Gov. Henry McMaster included a proposal in his Executive Budget for this year to add debit cards as an approved payment option for lottery tickets.

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

Nvidia’s Blackwell chip – the world’s most powerful AI chip to date – costs around US$40,000 per unit, and AI companies often ...

Rhaeos moved into Fulton Labs in January, effectively moving its headquarters from Evanston to Chicago. The company employs 17 people, most of whom work out of the Fulton Labs office — the others are ...

Cambodia’s GDP is projected to grow by 6.3 percent in 2025. This growth rate marks a return to pre-pandemic levels, supported ...